Telehorse SA (“Issuer”) informs that it received a signed copy of the letter of intent signed by Promotorzy Trading sp. z o.o. with its registered office in Warsaw (“Partner”), conducting business including the production and distribution of vaporizers (inhalers) in Poland and abroad.
According to the letter of intent referred to, both parties expressed their will to conduct negotiations aimed at agreeing terms of cooperation in the area of:
1) Partner’s support of R&D works carried out by the Issuer aimed at producing and introducing for sale of vaporization devices for medicinal purposes as well as oils and liquids with the main focus on products containing cannabinoids;
2) production under the Issuer’s own brand;
3) distribution through Partner’s sales channels. The letter of intent provides for negotiating and signing a cooperation agreement within 2 months.
The Issuer indicates that after changing the name to Cannabis Poland, it plans to conduct business in the production and sale of pharmaceutical and medical products with a focus on vaporizing products containing
cannabinoids made from hemp. Vaporizing products rich in cannabinoids is considered the most effective, effective and economical method of taking
cannabinoids.Cannabinoids are used in anti-inflammatory, analgesic, anxiolytic, antipsychotic and antispasmodic cures. They are used in Alzheimer’s disease, multiple sclerosis, leukemia, diabetes, asthma, epilepsy, spinal cord injuries, migraines, and withdrawal therapies. They help with rheumatic pains.
They have antiemetic and appetite stimulating properties, which is
essential for people during chemotherapy. They can also be used in the
process of rehab while fighting the addiction of smoking.The
size of the medical market, based on cannab is, is estimated in 2028 in
Poland at EUR 2 billion and at EUR 58 billion throughout Europe.